ArticleLeukemia2026
Correction: Strong constitutive NF-κB signaling in B cells drives SLL/CLL-like lymphomagenesis and overcomes microenvironmental dependencies.
Abstract readPublished Erratum
In one paragraph
Article in Leukemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
34 authors.
Valeria Soberón *Institute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Lena Osswald *Institute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Andrew MooreDepartment of Haematology, University of Cambridge, Cambridge, UK.
Dominika SosnowskaCancer Institute, University College London, London, UK.
Gene SwinerdInstitute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0001-9644-9109
Jingyu ChenDepartment of Haematology, University of Cambridge, Cambridge, UK.
Seren BaygünInstitute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-3198-7632
Carina DiehlInstitute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Gönül SeyhanInstitute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-3879-8009
Laura KrausInstitute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Vanessa GöllingInstitute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Ricarda TrappInstitute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Thomas J O'NeillResearch Unit Signaling and Translation, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.ORCID http://orcid.org/0000-0003-2253-3118
Sabrina BortoluzziInstitute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Daniel KovacsInstitute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Tim AmmonInstitute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Pankaj SingroulInstitute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0001-9855-1828
Yuliia HubarzhevskaInstitute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Rupert ÖllingerCenter for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-2292-5982
Sebastian MuellerCenter for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0009-0008-1514-3027
Olga BaranovCenter for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany.
Piero GiansantiCenter for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0003-2857-0841
Felix GillhuberDivision of Evolutionary Biology, Faculty of Biology, Ludwig-Maximilians-Universität (LMU) München, Planegg-Martinsried, Germany.ORCID http://orcid.org/0009-0007-9271-4340
Sonja GrathDivision of Evolutionary Biology, Faculty of Biology, Ludwig-Maximilians-Universität (LMU) München, Planegg-Martinsried, Germany.ORCID http://orcid.org/0000-0003-3621-736X
Oliver WeigertGerman Cancer Consortium (DKTK), Heidelberg, Germany.ORCID http://orcid.org/0000-0002-0987-7373
Andreas RosenwaldInstitute of Pathology, University of Würzburg, Würzburg, Germany.
Yoshiteru SasakiProgram in Cellular and Molecular Medicine, Children's Hospital, and Immune Disease Institute, Harvard Medical School, Boston, MA, USA.
Klaus RajewskyProgram in Cellular and Molecular Medicine, Children's Hospital, and Immune Disease Institute, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-6633-6370
Katja SteigerGerman Cancer Consortium (DKTK), Heidelberg, Germany.ORCID http://orcid.org/0000-0002-7269-5433
Florian BassermannCenter for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0003-4435-2609
Roland RadCenter for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-6849-9659
Daniel KrappmannResearch Unit Signaling and Translation, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.ORCID http://orcid.org/0000-0001-7640-3234
Ingo RingshausenDepartment of Haematology, University of Cambridge, Cambridge, UK.
Marc Schmidt-SupprianInstitute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany. marc.supprian@tum.de.ORCID http://orcid.org/0000-0002-8543-6166
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.